Table of Contents:

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Global Nasal Vaccines Market, By Vaccine Type
     • Global Nasal Vaccines Market, By Application
     • Global Nasal Vaccines Market, By Distribution Channel
     • Global Nasal Vaccines Market, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Rising burden of respiratory diseases or infections
     • Lack of healthcare infrastructure in developing economies
     • Increasing demand for safe and effective vaccines
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
4. Global Nasal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Nasal Vaccines Market, By Vaccine Type, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Live Attenuated Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Inactivated Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Subunit, Recombinant, and Conjugate Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Others (such as DNA Vaccines, Viral Vector Vaccines, etc.)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Nasal Vaccines Market, By Application, 2020-2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Influenza
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • COVID-19
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Other Respiratory Infections (such as RSV, Pneumococcal, etc.)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Others (such as Cholera, Typhoid, etc.)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Nasal Vaccines Market, By Distribution Channel, 2023-2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • Public
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
   • Private
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Nasal Vaccines Market, By Region, 2018-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 - 2030
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa
9. Competitive Landscape
   • AstraZeneca
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • GlaxoSmithKline plc
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Pfizer Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Serum Institute of India Pvt. Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • SINOVAC
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Bharat Biotech
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Altimmune
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • FluGen Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Vaxart
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Intravacc
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Gamma Vaccines Pty Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • BioNTech SE
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Analyst Views
10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 31 figures on "Global  Nasal Vaccines Market” – Global forecast to 2030